Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

361 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Profiling chromosomal-level variations in gastric malignancies.
Negoto T, Jo M, Nakayama I, Morioka M, Takeuchi K, Kawachi H, Hirota T. Negoto T, et al. Among authors: nakayama i. Cancer Sci. 2022 Nov;113(11):3864-3876. doi: 10.1111/cas.15544. Epub 2022 Sep 9. Cancer Sci. 2022. PMID: 36002148 Free PMC article.
Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer.
Wakatsuki T, Yamamoto N, Sano T, Chin K, Kawachi H, Takahari D, Ogura M, Ichimura T, Nakayama I, Osumi H, Matsushima T, Suenaga M, Shinozaki E, Hiki N, Ishikawa Y, Yamaguchi K. Wakatsuki T, et al. Among authors: nakayama i. J Gastroenterol. 2018 Nov;53(11):1186-1195. doi: 10.1007/s00535-018-1464-0. Epub 2018 Apr 9. J Gastroenterol. 2018. PMID: 29633013 Free PMC article.
Phase II trial of biweekly cetuximab and irinotecan as third-line therapy for pretreated KRAS exon 2 wild-type colorectal cancer.
Osumi H, Shinozaki E, Mashima T, Wakatsuki T, Suenaga M, Ichimura T, Ogura M, Ota Y, Nakayama I, Takahari D, Chin K, Miki Y, Yamaguchi K. Osumi H, et al. Among authors: nakayama i. Cancer Sci. 2018 Aug;109(8):2567-2575. doi: 10.1111/cas.13698. Epub 2018 Jul 13. Cancer Sci. 2018. PMID: 29908105 Free PMC article. Clinical Trial.
Randomized phase II study comparing neoadjuvant 5-fluorouracil/oxaliplatin/docetaxel versus docetaxel/oxaliplatin/S-1 for patients with type 4 or large type 3 gastric cancer.
Hashimoto T, Nakayama I, Ohashi M, Mizusawa J, Kawachi H, Kita R, Fukuda H, Kurokawa Y, Boku N, Yoshikawa T, Terashima M. Hashimoto T, et al. Among authors: nakayama i. Future Oncol. 2023 Oct;19(32):2147-2155. doi: 10.2217/fon-2023-0605. Epub 2023 Oct 26. Future Oncol. 2023. PMID: 37882373
Early gastric cancer with RhoGAP fusion is linked to frequent nodal metastasis and a part of microtubular-mucocellular histology.
Noda H, Sakata S, Baba S, Togashi Y, Nakano K, Hirasawa T, Nakayama I, Hata C, Takamatsu M, Sugawara E, Yamamoto N, Fujisaki J, Nunobe S, Iwakiri K, Takeuchi K, Kawachi H. Noda H, et al. Among authors: nakayama i. Gastric Cancer. 2024 May 16. doi: 10.1007/s10120-024-01507-4. Online ahead of print. Gastric Cancer. 2024. PMID: 38755445
361 results